Why the study?
Does remote monitoring improve clinical outcomes in patients with cardiac implantable electronic devices?
Does remote monitoring improve clinical outcomes in patients with cardiac implantable electronic devices?
This review critically appraises recent negative trial data on remote management of heart failure using implanted devices to discuss the future utility of remote monitoring.
Negative trials temper enthusiasm for remote HF monitoring via devices; leaves open utility of optimized strategies in future research.
In the era of communication technology, remote monitoring has been a paradigm shift in the way patients with cardiac implantable electronic devices are managed. It has been endorsed by scientific societies and is being increasingly adopted in the clinical setting. Despite the various advantages associated with this strategy, data on improved clinical outcome are still sparse. The recently published study on the remote management of heart failure using implanted devices and formalised follow-up procedures, which turned out to be negative, has cast doubt on whether remote monitoring should still be used. This article provides a critical appraisal of the study, and discusses the issue of remote data management.
No takes yet. Share an insight, caveat, or question.
Haran Burri (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: